The anti-tumour and proinflammatory actions of IL4
- 1 January 1993
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 144 (8), 633-637
- https://doi.org/10.1016/s0923-2494(05)80017-3
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Modulation of Tumor-Infiltrating Lymphocytes Derived from Human Renal Cell Carcinoma by Interleukin-4Journal of Immunotherapy, 1992
- An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4Science, 1992
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversityCell, 1991
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound formsCell, 1989
- Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.The Journal of Experimental Medicine, 1988
- Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.The Journal of Experimental Medicine, 1983